We are live on
!
Find out more
NTC
North Tide Capital Portfolio holdings
AUM
$469M
1-Year Est. Return
6.57%
This Fund
S&P 500
This Quarter
Est. Return
+14.27%
1 Year Est. Return
+6.57%
3 Year Est. Return
+14.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$564M
AUM Growth
–
Cap. Flow
+$529M
Cap. Flow
% of AUM
93.75%
Top 10 Holdings %
Top 10 Hldgs %
73.99%
Holding
23
New
23
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$44.9M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$44.7M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$42.8M |
| 4 |
Boston Scientific
BSX
|
+$42.4M |
| 5 |
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
|
+$33.9M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.53% |
| 2 | Consumer Discretionary | 3.15% |
| 3 | Financials | 2.01% |
Similar funds
SD
DG
NBC
JWM
JPCCM
MCL
GIIO
FC
North Tide Capital's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for North Tide Capital, which disclosed 23 positions worth $564M. Its ten largest holdings account for 74% of the portfolio.
Its largest position is Elevance Health: 600,000 shares worth $49.1M.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, followed by Consumer Discretionary and Financials.
- North Tide Capital's largest Q2 2013 buy was Elevance Health: 600,000 shares worth $49.1M.
- North Tide Capital's ten largest holdings make up 74% of its $564M portfolio in Q2 2013.
- North Tide Capital disclosed 23 positions in Q2 2013, its first 13F filing on record.
Based on North Tide Capital's 13F filing for Q2 2013, filed 14 Aug 2013.